Forrest Roth
Plastic Surgery · Houston, TXNPI 1831333517
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Merz North America, Inc. at 35.6% of the total. Reporting peaked in 2022 at $2,760 and has fallen 58.1% since, to $1,158 in 2025.
Across 224 payments — averaging $46.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$4K
- Galderma Laboratories, L.p.$3K
- AbbVie$2K
- Mentor Worldwide LLC$870
- Sientra, Inc.$811
- Revance Therapeutics, Inc.$452
- plus $425 from 8 others
What the payments were for
- Food & beverage$10,313100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 20 | $3,668 |
| Galderma Laboratories, L.p. | 76 | $2,557 |
| AbbVie(2 entities) | 80 | $1,531 |
| Mentor Worldwide LLC | 15 | $870 |
| Sientra, Inc. | 13 | $811 |
| Revance Therapeutics, Inc. | 7 | $452 |
| Zimmer Biomet | 2 | $131 |
| Medline Industries LP | 2 | $89 |
| Acclarent, Inc | 1 | $65 |
| Acelrx Pharmaceuticals, Inc. | 3 | $42 |
| Vertical Pharmaceuticals, LLC | 2 | $36 |
| Smith+Nephew | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| VYNE Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,313 in reported general payments places this provider in the 80th percentile of 337 plastic surgery providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $143 |
| Methylprednisolone | 19 | $136 |
| Clindamycin Hcl | 19 | $101 |
| Alprazolam | 16 | $20 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Houston
- Younghoon ChoHouston$1.2M
- David AdelmanHouston$405K
- Warren EllsworthHouston$284K
- Camille CashHouston$212K
- Robert YarishHouston$180K
- Alexander MericliHouston$125K
- Kristy HamiltonHouston$70K
- Jenny NguyenHouston$45K
- Patrick HsuHouston$34K
- Anthony EchoHouston$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.